<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
---------------
SEC FILE NUMBER
033-14042 - NY
---------------
---------------
CUSIP NUMBER
64124R 10 7
---------------
(CHECK ONE):
/ / Form 10-KSB / / Form 11-K / / Form 20-F /X/ Form 10-QSB / / Form N-SAR
For Period Ended: March 31, 1997
Nothing in this Form shall be construed to imply that the Commission has
verified any information herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
----------------------------------
PART I -- REGISTRANT INFORMATION
FULL NAME OF REGISTRANT (Former Name, if Applicable)
NEUROCORP, LTD.
Address of Principal Executive Office (Street and Number)
150 WHITE PLAINS ROAD
City, State and Zip Code
TARRYTOWN, NEW YORK 10591
PART II -- RULES 12b-25(b) AND (c)
If the subject report could not be filed without reasonable effort or expense
and the Registrant seeks relief pursuant to Rule 12b-25(b), the following
should be completed. (Check box if appropriate)
/X/ (a) The reasons described in reasonable detail in Part II of this
form could not be eliminated without unreasonable effort or
expense;
/X/ (b) The subject quarterly report on Form 10-QSB, will be filed on or
before the fifth calendar day following the prescribed due date.
/ / (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
<PAGE>
PART III -- NARRATIVE
State below in reasonable detail the reason why the Form 10-QSB could not be
filed within the prescribed time period.
Registrant is changing its internal chart of accounts so as to improve its
accounting system which has delayed the completion of the Form 10-QSB.
The inability to file timely could not be eliminated by the Registrant
without unreasonable effort and expense in that until such change has been
completed, it cannot finalize its financial statements.
PART IV -- OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
AILEEN A. KUNITZ (914) 631-3316
---------------------------------- ----------------- ----------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under section 13 or 15(d) of the
Securities Exchange Act of 1934 or section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period
that the registrant was required to file such report(s) been filed? If
the answer is no, identify report(s). /X/ Yes / / No
---------------------------------------------------------------------------
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected
by the earnings statement to be included in the subject report or
portion thereof? If so: attach an explanation of the anticipated change,
both narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made. / / Yes /X/ No
- -------------------------------------------------------------------------------
<PAGE>
NEUROCORP, LTD.
---------------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Dated: May 15, 1997 By: /s/ AILEEN A. KUNITZ
----------------------------
AILEEN A. KUNITZ
CFO
